You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Nicotine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for nicotine and what is the scope of patent protection?

Nicotine is the generic ingredient in nine branded drugs marketed by Dr Reddys Labs Sa, Chattem Sanofi, Difgen Pharms, Mcneil Cons, Aveva, Pfizer, Pfizer Inc, Haleon Us Holdings, Fertin Pharma, Ivax Sub Teva Pharms, L Perrigo Co, P And L, Perrigo R And D, Glaxosmithkline Cons, Aurobindo Pharma, Aurobindo Pharma Ltd, Pld Acquisitions, and Ppi-dac, and is included in sixty-two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirty drug master file entries for nicotine. Twenty-nine suppliers are listed for this compound.

Summary for nicotine
Drug Prices for nicotine

See drug prices for nicotine

Drug Sales Revenue Trends for nicotine

See drug sales revenues for nicotine

Recent Clinical Trials for nicotine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Anna Stanhewicz, PhDEarly Phase 1
Spaulding Rehabilitation HospitalEarly Phase 1
Multidisciplinary Association for Psychedelic StudiesEarly Phase 1

See all nicotine clinical trials

Pharmacology for nicotine
Medical Subject Heading (MeSH) Categories for nicotine
Paragraph IV (Patent) Challenges for NICOTINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NICODERM CQ Transdermal System nicotine 7 mg/24 hrs 14 mg/24 hrs 21 mg/24 hrs 020165 1 2014-05-30

US Patents and Regulatory Information for nicotine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
P And L NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 208875-001 Oct 31, 2019 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
P And L NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 079044-001 Jul 8, 2009 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings NICORETTE nicotine polacrilex TROCHE/LOZENGE;ORAL 021330-002 Oct 31, 2002 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
P And L NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 212056-002 Jul 26, 2019 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo R And D NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 077007-001 Jan 31, 2006 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for nicotine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ⤷  Sign Up ⤷  Sign Up
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-004 Aug 2, 1996 ⤷  Sign Up ⤷  Sign Up
Pfizer NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 ⤷  Sign Up ⤷  Sign Up
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 ⤷  Sign Up ⤷  Sign Up
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 ⤷  Sign Up ⤷  Sign Up
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.